Welcome to the Men’s Health Policy Center
The Men’s Health Policy Center (MHPC) is a public policy resource tool that enables the reader to better understand legislative and regulatory issues, empowering them to better advocate for the health and well being of men and their families.
The goal of the Men’s Health Policy Center (MHPC) is to improve the lives of every person by providing him or her with the tools necessary to make change. MHPC helps to empower individuals by offering strategies and tools that are helpful in advocating for their issues.
On federal and state levels, MHPC offers information about key legislation and government initiatives, and the impact those initiatives might have on men and their families. As a part of that process, MHPC will periodically host letter-writing campaigns and other action vehicles for individuals to voice their concern about key issues.
MHPC neither endorses nor opposes candidates, specific legislation, or regulatory initiatives.
Key Coalitions and Initiatives
One Voice Against Cancer (OVAC)
One Voice Against Cancer (OVAC), a collaboration of national non-profit organizations representing millions of Americans, delivers a unified message to Congress and the White House on the need for increased cancer-related appropriations at the National Institutes of Health and the Centers for Disease Control and Prevention.
Click here to learn more.
Thomas J. Manton Prostate Cancer Early Detection and Treatment Act
- This bill is expected to be reintroduced in 2009 and will provide federal funding through Centers for Disease Control and Prevention (CDC) for both prostate cancer screenings and treatment for low and moderate income men.
- Will be modeled after the Breast and Cervical Cancer programs already in existence at CDC.
The PRIME Act: Prostate Cancer Detection
The Prostate Research, Imaging, and Men’s Education Act (PRIME Act) is expected to be reintroduced in 2009 and will provide $650 million to the National Institutes of Health and the U.S. Department of Health and Human Services over 5 years for prostate cancer imaging, research and education.